EP PerMed Fast Track Call for Startups and Researchers in Europe in 2025
Are you an innovator in Personalised Medicine looking for an accelerated pathway to bring your solutions to market? The European Partnership for Personalised Medicine (EP PerMed) is now inviting applications for the EP PerMed - Fast Track Call. Designed to support startups, small teams, and researchers, this programme offers a significant funding opportunity of up to €80,000 per project to help validate your personalised medicine solutions.
The Fast Track Validation Programme: Empowering Personalised Medicine Innovators
The Fast Track Validation Programme is tailored to bridge the crucial gap between innovation and market readiness by providing a structured, accelerated validation pathway. By leveraging a network of top-tier validation centres, the programme aims to help participants secure critical evidence and feedback within just six months.
EP PerMed emphasizes the value of transitioning from a "one size fits all" approach to Personalised Medicine (PM), focusing on healthcare strategies that cater to individuals' unique biological features, lifestyle, and environmental factors. The Fast Track Call is a part of EP PerMed’s broader initiative to enhance the adoption and development of PM solutions across Europe.
Programme Timeline and Key Dates
Mark your calendars with the following key dates for the Fast Track Call:
- Call for proposals opens: December 10, 2024
- Application submission deadline: March 13, 2025
- Final report submission deadline: January 30, 2026
A pre-application webinar will be held on January 21, 2025, offering detailed guidance on the application process.
Programme Aims and Expected Outcomes
The Fast Track Validation Programme aims to facilitate the development and market readiness of at least five PM solutions in 2025. Participants will gain from a host of benefits, including:
- Advancing their projects by at least one technology readiness level (TRL)
- Receiving user feedback to refine their innovations
- Demonstrating the efficacy and safety of their solutions.
Support and Funding
Selected projects will receive up to €80,000, primarily for validation services. The funding includes a pre-payment of 50% at the start and the remaining sum upon the approval of post-validation activities.
Who Can Apply?
The Fast Track Call is open to startups and researchers focusing on PM solutions that are ready for the proof-of-concept stage (TRL3). Eligibility criteria include:
- Being registered in an EU Member State or a Horizon Europe-associated country
- Submitting the application in English
Eligible technologies include AI and Big Data, Digital solutions, fitting into the Information and Communication Technologies (ICT) domain.
Application and Evaluation Process
To apply, visit the EP PerMed Fast Track Call webpage and download the related documents such as:
Applications must be submitted via the EIT Health Application Platform by March 13, 2025.
An independent evaluation panel will assess each submission based on criteria such as innovativeness, management capacity, market opportunity, co-creation and validation needs, and business model.
Contact Information
For further inquiries, you can contact Mohammed Ilyass Rahmouni at calls_eppermed@eithealth.eu.
Don’t miss this chance to accelerate your PM innovations and bring cutting-edge healthcare solutions to the market! Apply now and join the EP PerMed - Fast Track Call to secure the support you need to succeed.
For more details and to apply, visit the EP PerMed Fast Track Call webpage.
FAQ
1. What is the EP PerMed Fast Track Call?
The EP PerMed Fast Track Call is an accelerated validation programme designed to support start-ups, small teams, and researchers in Personalised Medicine, providing up to €80,000 per project to help validate their solutions. Learn more about the Fast Track Call
2. What is the aim of the EP PerMed's Fast Track Validation Programme?
The aim of the programme is to accelerate the development and market readiness of at least five innovative Personalised Medicine solutions in 2025 by providing a structured validation pathway. Discover more about the programme's aims
3. Who can apply for the EP PerMed Fast Track Call?
Eligible applicants include start-ups and researchers focusing on Personalised Medicine solutions that are at least at the proof-of-concept stage (TRL3), registered in an EU Member State or a Horizon Europe-associated country. Check eligibility criteria
4. What type of funding is available through the Fast Track Call?
Selected projects will receive up to €80,000 in funding, with a pre-payment of 50% at the start and the remaining sum upon the approval of post-validation activities. Learn about the funding process
5. What are the key dates for the Fast Track Call?
Key dates include the opening of the call on December 10, 2024, the application deadline on March 13, 2025, and the final report submission deadline on January 30, 2026. View the full timeline
6. How will the applications be evaluated for the Fast Track Call?
Applications will be evaluated by an independent panel of experts based on criteria such as innovativeness, management capacity, market opportunity, co-creation and validation needs, and business model. Read about the evaluation process
7. What is the process after an application is pre-selected?
Pre-selected projects will need to provide a detailed validation plan and, if required, submit ethical approval applications before contracting. The final funding decision will be based on these elements. Understand the post-selection process
8. What are the expected outcomes of the Fast Track Validation Programme?
Participants will rigorously test and refine their innovations, advancing their projects by at least one TRL and demonstrating efficacy and safety, ultimately facilitating smoother transitions from development to commercialisation. Learn about expected outcomes
9. How can I register for the EP PerMed Fast Track Call webinar?
An online pre-application webinar will be held on January 21, 2025. Prospective applicants can register through the provided link. Register for the webinar
10. What is the role of validation centres in the Fast Track Call?
Validation centres provide the necessary infrastructure and expertise to test and validate innovative Personalised Medicine solutions, ensuring they meet end-user needs and regulatory requirements. Learn more about validation centres